Ernexa Therapeutics Inc. Area of Real Estate Property
Ernexa Therapeutics Inc. (ERNA) had Area of Real Estate Property of 45.50 thousand sqft as of 2022-10-31, per its 10-K filed 2025-03-12.
Financial Statements › Notes
us-gaap:AreaOfRealEstateProperty · last filed 2025-03-12
- 2022-10-31: Area of Real Estate Property 45.50K sqft.
- 2022-10-18: Area of Real Estate Property 45.50K sqft.
| Period end | Area of Real Estate Property |
|---|---|
| 2022-10-31 | 45.50K sqft 10-K · filed 2025-03-12 |
| 2022-10-18 | 45.50K sqft 10-K · filed 2023-03-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Pulmatrix, Inc. (PULM) | United States | $0.006B | |
| ProPhase Labs, Inc. (PRPH) | United States | $0.006B | -0.06 |
| Xenetic Biosciences, Inc. (XBIO) | United States | $0.006B | |
| Enveric Biosciences, Inc. (ENVB) | United States | $0.007B | -0.63 |
| Bolt Biotherapeutics, Inc. (BOLT) | United States | $0.007B | -0.26 |
| SYNLOGIC, INC. (SYBX) | United States | $0.007B | |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |
| Processa Pharmaceuticals, Inc. (PCSA) | United States | $0.005B | |
| AMARIN CORP PLC\UK (AMRN) | $0.005B | -247.24 | |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B |